ECG Telemetry Devices Market is expected to reach US$ 2,087.66 million by 2028

by Sameer Joshi or 18-May-2021
Increasing Incidence of Cardiovascular Disease Drives Growth of ECG Telemetry Devices Market during 2021–2028
According tour new research study on “ECG Telemetry Devices Market Forecast t2027 – COVID-19 Impact and Global Analysis – by Product and End User,” the market is expected treach US$ 3,783.48 million by 2028 from US$ 2,087.66 million in 2020; it is estimated tgrow at a CAGR of 7.8% from 2021 t2028. The report highlights major market drivers and prominent companies along with their key developments in the market. 
The world has been witnessing notable developments in mobile health (mHealth) from the last decade, which is offering physicians and patients new approaches tmanage many diseases, including atrial arrhythmias, ventricular arrhythmias, ventricular, atrial fibrillation. The growing prevalence of arrhythmia and other cardiovascular diseases (CVDs) is triggering the need for improved diagnostic methods. ECG telemetry systems are the most effective instruments used for detecting arrhythmias. These devices allow simpler and quicker heart monitoring, which has added ttheir popularity. According tthe World Health Organization (WHO), CVDs are the leading cause of death worldwide, with ~30 million people experiencing a stroke each year. According tthe American Heart Association, almost half of all adults in the US have a kind of CVD. More than 130 million people, i.e., 45.1%, of the US population are projected thave a type of CVD by 2035. Furthermore, the European Society of Cardiology reported that Atrial fibrillation is the most common arrhythmia, and it accounts for 0.28–2.6% of healthcare spending in European countries. It alsmentioned that patients suffering from atrial fibrillation at a five-times greater risk of getting a stroke, and 20–30% of total stroke cases in Europe are caused due tatrial fibrillation. As per the study conducted by the European Society of Cardiology in 2016, in the EU, ~7.6 million people with age 65 years and above had atrial fibrillation. As per the European Society of Cardiology estimates, the number is expected tincrease by 89% treach ~14.4 million by 2060. The prevalence of atrial fibrillation is estimated treach 9.5% by 2060 from 7.8% in 2016. Further, as per the report “Beyond the Burden: The Impact of Atrial Fibrillation in Asia Pacific” by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation , and the number is expected treach ~72 million by 2050. The report alssuggests that the condition has affected the middle-aged and elderly population more. 

A few of the primary risk factors for CVDs are family history, ethnicity, and age; other risk factors include tobaccconsumption, hypertension, obesity, high cholesterol, physical inactivity, diabetes, unhealthy diets, and alcohol consumption. Further, lifestyle changes are leading tthe rise in the incidence of diseases such as diabetes, hypertension, dyslipidemia, and obesity, contributing ta surge in CVD cases across the world. Most types of CVDs can be prevented through pre-monitoring and pre-diagnosis. Likewise, abnormalities in the functioning of the heart, arrhythmias, can be averted with early diagnosis. Owing tthis, the demand for ECG telemetry devices is increasing as these devices help save patients at high risk of cardiac arrest.
Geographically, the ECG telemetry devices market is segmented intNorth America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. In North America, the US is the largest market for ECG telemetry devices. The market growth in the region is attributed tthe key driving factors such as the presence of key market players and their engagement in product developments. In addition, the increase in cardiovascular disease incidence and surge in geriatric population are among the prominent factors propelling the market growth in North America.
Cardiac Science Corporation, CompuMed Inc., GE Healthcare Inc., Medtronic Inc., Mindray Medical International Ltd., Nihon Kohden Corporation, Philips Healthcare, ScottCare Corporation, Dragger, and Welch Allyn Inc are among the leading companies operating in the ECG telemetry devices market. 
The report analyzes ECG telemetry devices market on the basis of following segments:
By Product
  • Resting ECG Devices
  • Stress ECG Devices
  • Others
By End User
  • Home Healthcare
  • Hospitals 
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America  
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: